Sage Therapeutics, Inc. revenue for the last year amounted to 86.45 M USD, the most of which — 86.45 M USD — came from its highest performing source at the moment, Novel Medicines, the year earlier bringing 7.69 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sage Therapeutics, Inc. 86.45 M USD, and the year before that — 7.69 M USD.